Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Organic Synthesis
Organic synthesis is a vibrant and rapidly evolving field; we can now cyclize amines directly onto alkenes. Like the first two books in this series, Organic Synthesis: State of the Art 2003-2005 and Organic Synthesis: State of the Art 2005-2007, this reference leads readers quickly to the most important recent developments. Two years of Taber's popular weekly online column, "Organic Chemistry Highlights", as featured on the organic-chemistry.org website, are consolidated here, with cumulative indices of all three volumes in this series. Important topics that are covered range from powerful new methods for C-C bond construction to asymmetric organocatalysis and direct C-H functionalization. This go-to reference focuses on the most important recent developments in organic synthesis, and includes a succinct analysis of the significance and applicability of each new synthetic method. It details and analyzes more than twenty complex total syntheses, including the Sammakia synthesis of the Macrolide RK-397, the Ley synthesis of Rapamycin, and the Kobayashi synthesis of (-)-Norzoanthamine.
Ion-motive ATPases
The large body of recent knowledge that has allowed the recent discovery of new ATPases and the partial clarification of structural and functional aspects of the already known ATPases are the subjects of this volume. A dozen ION-MOTIVE ATPases are discussed in terms of structure, site modification, catalysis, expression, hormonal and metabolic regulation and pharmacologic intervention.
Annals of the New York Academy of Sciences
Records of meetings 1808-1916 in v. 11-27.
Organic Synthesis
A collection of Douglass Taber's columns originally published between 2013 - 2015 at www.organicchemistry.org
L'Actualité chimique
None
Neuroimaging biomarkers in Alzheimer’s disease
In view of the growing prevalence of AD worldwide, there is an urgent need for the development of better diagnostic tools and more effective therapeutic interventions. Indeed, much work in this field has been done during last decades. As such, a major goal of current clinical research in AD is to improve early detection of disease and presymptomatic detection of neuronal dysfunction, concurrently with the development of better tools to assess disease progression in this group of disorders. All these putative correlates are commonly referred to as AD-related biomarkers. The ideal biomarker should be easy to quantify and measure, reproducible, not subject to wide variation in the general popul...
